ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome

This study has been completed.
Study NCT00001839.   Last updated on March 3, 2008.   Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Hematologic Diseases
Myelodysplastic Syndromes
2 Additional conditions recognized in this trial
Preleukemia
Syndrome
3 More general conditions related to this trial
Bone Marrow Diseases
Disease
Neoplasms
Pathologic Processes
Precancerous Conditions
4 Interventions listed in this trial
Antithymocyte globulin
Cyclosporine
5 Additional drug interventions recognized in this trial
Antilymphocyte Serum
Cyclosporins
6 More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
7 Sponsors listed in this trial
National Institutes of Health Clinical Center (CC)




Links to all studies - primarily for crawlers